Chapman Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-71,677
Closed -$5.31M 31
2025
Q2
$5.31M Sell
71,677
-10,479
-13% -$729K 3.71% 12
2025
Q1
$6.63M Sell
82,156
-915
-1% -$78.6K 4.95% 9
2024
Q4
$6.49M Buy
83,071
+292
+0.4% +$24.8K 4.83% 9
2024
Q3
$7.77M Sell
82,779
-603
-0.7% -$50.6K 5.68% 7
2024
Q2
$6.5M Sell
83,382
-4,003
-5% -$327K 4.94% 9
2024
Q1
$7.94M Sell
87,385
-1,288
-1% -$107K 5.85% 6
2023
Q4
$6.86M Buy
88,673
+614
+0.7% +$43K 5.22% 8
2023
Q3
$5.99M Buy
88,059
+2,815
+3% +$205K 5.07% 9
2023
Q2
$6.93M Buy
85,244
+72
+0.1% +$5.75K 5.49% 6
2023
Q1
$6.99M Buy
+85,172
New +$6.08M 5.75% 7

Other funds holding GEHC

Chapman Investment Management's GEHC Position: Q3 2025 in Review

Chapman Investment Management sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 71,677 shares — an estimated $5.31M sold.

Chapman Investment Management first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $7.94M in Q1 2024. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Chapman Investment Management reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Chapman Investment Management sold 71,677 GE HealthCare shares in Q3 2025, an estimated $5.31M.
  • Chapman Investment Management first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Chapman Investment Management's GE HealthCare position peaked at $7.94M in Q1 2024.
  • 1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Chapman Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.